^
BIOMARKER:

STK11 mutation + KEAP1 mutation

i
Other names: Serine/Threonine-Protein Kinase 11, Liver Kinase B1, Serine/Threonine-Protein Kinase LKB1, Polarization-Related Protein LKB1, STK11, Serine/Threonine Kinase 11, Serine/Threonine-Protein Kinase STK11, Renal Carcinoma Antigen NY-REN-19, KEAP1, Kelch Like ECH Associated Protein 1, Cytosolic Inhibitor Of Nrf2, Kelch-Like Family Member 19, Kelch-Like Protein 19, KLHL19, INrf2, KEAP1 Delta C, KIAA0132, INRF2
Entrez ID:
Related biomarkers:
STK11 mutation + KEAP1 mutation
Lung Non-Squamous Non-Small Cell Cancer
rivoceranib + camrelizumab
Sensitive: C3 – Early Trials
STK11 mutation + KEAP1 mutation
NSCLC
PD-L1 inhibitor
Sensitive: C3 – Early Trials
STK11 mutation + KEAP1 mutation
NSCLC
rivoceranib + camrelizumab
Sensitive: C3 – Early Trials
STK11 mutation + KEAP1 mutation
NSCLC
Immunotherapy
Resistant: C3 – Early Trials